Prasad on Medicine

• Public Commenting Has Been Hijacked by Biopharma In a recent analysis, 1 in 2 'public commenters' giving input on state-level drug coverage decisions was someone with financial ties to the pharmaceutical industry.
  Medscape Oncology, November 21, 2019
• 'Making Room' for a New Generation of Medical Leaders Vinay Prasad outlines 10 ways that senior faculty members can help junior researchers advance professionally.
  Medscape Oncology, September 05, 2019
• On Twitter, and in Life, Aim to Persuade the Swing Voter Vinay Prasad talks about the ways in which #MedTwitter shines, as well as how medical debates, both online and at medical conferences, could be improved.
  Medscape Oncology, June 13, 2019
• Med Student 'Influencers' No Different From MDs on Pharma Payroll   There is hypocrisy behind the backlash against medical students who make money from their social media influence, argues Vinay Prasad.
  Medscape Oncology, May 09, 2019
• Why 'Don't Make Enemies' Is Cowardly Advice Don't make enemies or don't make it personal? Vinay Prasad discusses the difference between good advice and cowardice.
  Medscape Oncology, February 05, 2019
• True Patient Advocates Must Be Students of Evidence-Based Medicine Vinay Prasad discusses ways in which well-meaning but misguided patient advocates inadvertently lobby for medical advances that may not be in patients' best interest.
  Medscape Oncology, December 27, 2018
• 21st Century Physician: Triaging the Tsunami of Medical Information Vinay Prasad describes his essential tips to separate fact from spin in medical studies.
  Medscape Oncology, September 25, 2018
• 'Twitter Cheerleaders': A Megaphone for Bad Science A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay Prasad.A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay Pra
  Medscape Oncology, September 19, 2018
• When Do We Need RCTs, and When Can We Manage Without Them? A recent debate on Twitter over the use of inferior vena cava filters reinforces the value of conducting randomized controlled trials in medicine, argues Dr Vinay Prasad.
  Medscape Oncology, August 07, 2018
• FDA's Genomic Screening Approval Blurs Research and Practice   The FDA's approval of broad genomic testing for patients with cancer will bring unproven therapies into clinical practice, argues Vinay Prasad.
  Medscape Oncology, June 28, 2018
• Calling Out the FDA's 'We Don't Regulate Medicine' Mantra Dr Vinay Prasad calls the FDA to task over the differing standards the agency uses to grant drug approvals and expanded indications.
  Medscape Oncology, May 24, 2018
• Vinay Prasad: Why I'm Writing for Medscape Vinay Prasad introduces his new Medscape column.
  Medscape Oncology, May 14, 2018